Researchers at the University Hospital Bonn (UKB) and the University of Bonn have discovered how a small, naturally occurring RNA molecule in the kidney activates a mutated immune receptor, triggering ...

Clonal hematopoiesis of indeterminate potential (CHIP) is a known risk factor for coronary artery disease, though its precise role in disease progression continues to emerge. This study leverages ...

Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...

Microbes such as viruses, bacteria, and protozoa often cause infections in a variety of organisms, with the course and outcome of these infections being shaped by intricate interactions between the ...

CREATE Medicines ("CREATE") broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, ...